These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33825333)

  • 1. Efficacy and tolerability of a detergent and care component for rosacea patients: A split-face, vehicle-controlled, randomized trial.
    Guertler A; Niesert AC; Wilhelm KP; Knuhr K; Brandt M; French LE; Reinholz M
    J Cosmet Dermatol; 2022 Feb; 21(2):689-697. PubMed ID: 33825333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
    Baumann L; Goldberg DJ; Stein Gold L; Tanghetti EA; Lain E; Kaufman J; Weng E; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Mar; 17(3):290-298. PubMed ID: 29537447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.
    Kircik LH; DuBois J; Draelos ZD; Werschler P; Grande K; Cook-Bolden FE; Weng E; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Jan; 17(1):97-105. PubMed ID: 29320594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin compatibility and efficacy of a cosmetic skin care regimen with licochalcone A and 4-t-butylcyclohexanol in patients with rosacea subtype I.
    Schoelermann AM; Weber TM; Arrowitz C; Rizer RL; Qian K; Babcock M
    J Eur Acad Dermatol Venereol; 2016 Feb; 30 Suppl 1():21-7. PubMed ID: 26805419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety results of micellar water, cream and serum for rosacea in comparison to a control group.
    Guertler A; Jøntvedt NM; Clanner-Engelshofen BM; Cappello C; Sager A; Reinholz M
    J Cosmet Dermatol; 2020 Oct; 19(10):2627-2633. PubMed ID: 32623833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study.
    Eichenfield LF; Del Rosso JQ; Tan JKL; Hebert AA; Webster GF; Harper J; Baldwin HE; Kircik LH; Stein-Gold L; Kaoukhov A; Alvandi N
    Br J Dermatol; 2019 May; 180(5):1050-1057. PubMed ID: 30500065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea-prone skin.
    Baldwin H; Santoro F; Lachmann N; Teissedre S
    J Cosmet Dermatol; 2019 Dec; 18(6):1686-1692. PubMed ID: 30803131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.
    Gold LS; Papp K; Lynde C; Lain E; Gooderham M; Johnson S; Kerrouche N
    J Drugs Dermatol; 2017 Sep; 16(9):909-916. PubMed ID: 28915286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy.
    Deaver Peterson J; Katz TM
    J Cosmet Dermatol; 2019 Dec; 18(6):1758-1764. PubMed ID: 31017734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial.
    Draelos ZD; Gold MH; Weiss RA; Baumann L; Grekin SK; Robinson DM; Kempers SE; Alvandi N; Weng E; Berk DR; Ahluwalia G
    J Am Acad Dermatol; 2018 Jun; 78(6):1156-1163. PubMed ID: 29409914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.
    Tanghetti EA; Dover JS; Goldberg DJ; Dhawan SS; Luo L; Berk DR; Ahluwalia G; Alvandi N
    J Drugs Dermatol; 2018 Jun; 17(6):621-626. PubMed ID: 29879249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A.
    Weber TM; Ceilley RI; Buerger A; Kolbe L; Trookman NS; Rizer RL; Schoelermann A
    J Cosmet Dermatol; 2006 Sep; 5(3):227-32. PubMed ID: 17177744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With Rosacea.
    Kuang AW; DuBois J; Attar M; Ahluwalia G
    J Drugs Dermatol; 2018 Feb; 17(2):213-220. PubMed ID: 29462230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2 Randomized, Dose-Ranging Study of Oxymetazoline Cream for Treatment of Persistent Facial Erythema Associated With Rosacea.
    DuBois J; Dover JS; Jones TM; Weiss RA; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Mar; 17(3):308-316. PubMed ID: 29537449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.
    Layton AM; Schaller M; Homey B; Hofmann MA; Bewley AP; Lehmann P; Nohlgård C; Sarwer DB; Kerrouche N; Ma YM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2405-10. PubMed ID: 26416154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and safety of Oxymetazoline cream 1% on rosacea-associated erythema: A systematic review and analysis of clinical evidence.
    Yuan X; Yin D
    J Cosmet Dermatol; 2023 Jan; 22(1):103-110. PubMed ID: 36237138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials.
    Stein-Gold L; Kircik L; Draelos ZD; Werschler P; DuBois J; Lain E; Baumann L; Goldberg D; Kaufman J; Tanghetti E; Ahluwalia G; Alvandi N; Weng E; Berk D
    J Drugs Dermatol; 2018 Nov; 17(11):1201-1208. PubMed ID: 30500142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.
    Fowler J; Jackson M; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M
    J Drugs Dermatol; 2013 Jun; 12(6):650-6. PubMed ID: 23839181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a simple image-based tool to quantify facial erythema in rosacea during treatment.
    Logger JGM; de Jong EMGJ; Driessen RJB; van Erp PEJ
    Skin Res Technol; 2020 Nov; 26(6):804-812. PubMed ID: 32537843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.